Occurrence of breast cancer subtypes in adolescent and young adult women
暂无分享,去创建一个
[1] Rudolph P. Rull,et al. An excess of breast cancer among young California-born Asian women. , 2011, Ethnicity & disease.
[2] J. Gittelsohn,et al. Association of Race/Ethnicity, Socioeconomic Status, Acculturation, and Environmental Factors with Risk of Overweight Among Adolescents in California, 2003 , 2008, Preventing chronic disease.
[3] V. Shavers,et al. Racial/ethnic variation in clinical presentation, treatment, and survival among breast cancer patients under age 35 , 2003, Cancer.
[4] J. Reis-Filho,et al. Basal-like breast cancer and the BRCA1 phenotype , 2006, Oncogene.
[5] L. Bernstein,et al. Receptors, associations, and risk factor differences by breast cancer subtypes: positive or negative? , 2011, Journal of the National Cancer Institute.
[6] D. Jeffe,et al. Elevated breast cancer mortality in women younger than age 40 years compared with older women is attributed to poorer survival in early-stage disease. , 2009, Journal of the American College of Surgeons.
[7] M. Gail,et al. Cumulative absolute breast cancer risk for young women treated for Hodgkin lymphoma. , 2005, Journal of the National Cancer Institute.
[8] H. Honoré,et al. Breast cancer in young women. , 1979, British medical journal.
[9] D. Toppmeyer,et al. Breast cancer in young women (YBC): prevalence of BRCA1/2 mutations and risk of secondary malignancies across diverse racial groups. , 2009, Annals of oncology : official journal of the European Society for Medical Oncology.
[10] C. Perou,et al. Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. , 2006, JAMA.
[11] R. Tibshirani,et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[12] K. Hede. Breast cancer testing scandal shines spotlight on black box of clinical laboratory testing. , 2008, Journal of the National Cancer Institute.
[13] S. Narod. Breast cancer in young women , 2012, Nature Reviews Clinical Oncology.
[14] C. Parise,et al. Variation in breast cancer subtypes with age and race/ethnicity. , 2008, Critical reviews in oncology/hematology.
[15] Anthony Rhodes,et al. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. , 2006, Archives of pathology & laboratory medicine.
[16] C. Schmidt. Lack of progress in teen and young adult cancers concerns researchers, prompts study. , 2006, Journal of the National Cancer Institute.
[17] M. Sherman,et al. Qualitative age interactions in breast cancer studies: mind the gap. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[18] W. Willett,et al. Longitudinal study on the role of body size in premenopausal breast cancer. , 2006, Archives of internal medicine.
[19] Anthony Rhodes,et al. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. , 2010, Archives of pathology & laboratory medicine.
[20] Victoria L. Cafourek,et al. Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies. , 2011, Journal of the National Cancer Institute.
[21] W. Thompson,et al. Risk factors by molecular subtypes of breast cancer across a population-based study of women 56 years or younger , 2011, Breast Cancer Research and Treatment.
[22] E. Chang,et al. Asian ethnicity and breast cancer subtypes: a study from the California Cancer Registry , 2011, Breast Cancer Research and Treatment.
[23] L. Bernstein,et al. Is There a Difference in the Association between Percent Mammographic Density and Subtypes of Breast Cancer? Luminal A and Triple-Negative Breast Cancer , 2009, Cancer Epidemiology Biomarkers & Prevention.
[24] A. Kurian. BRCA1 and BRCA2 mutations across race and ethnicity: distribution and clinical implications , 2010, Current opinion in obstetrics & gynecology.
[25] L. Holmberg,et al. Breast Cancer in Young Women: Poor Survival Despite Intensive Treatment , 2009, PloS one.
[26] Christian A. Rees,et al. Molecular portraits of human breast tumours , 2000, Nature.
[27] Krystyna Kiel,et al. Breast cancer. Clinical practice guidelines in oncology. , 2009, Journal of the National Comprehensive Cancer Network : JNCCN.
[28] P. Porter,et al. Reproductive and hormonal risk factors for postmenopausal luminal, HER‐2‐overexpressing, and triple‐negative breast cancer , 2009, Cancer.
[29] David M. Thomas,et al. The distinctive biology of cancer in adolescents and young adults , 2008, Nature Reviews Cancer.
[30] Marilie D. Gammon,et al. Breast cancers among very young premenopausal women (United States) , 2003, Cancer Causes & Control.
[31] D. Hoyert,et al. Annual Summary of Vital Statistics: 2006 , 2008, Pediatrics.
[32] M. Sherman,et al. Recent trends in breast cancer among younger women in the United States. , 2008, Journal of the National Cancer Institute.
[33] S. Coughlin,et al. Racial and ethnic disparities in breast cancer rates by age: NAACCR Breast Cancer Project , 2005, Breast Cancer Research and Treatment.
[34] Diane D. Liu,et al. Early onset HER2‐positive breast cancer is associated with germline TP53 mutations , 2012, Cancer.
[35] R. Cress,et al. Descriptive analysis of estrogen receptor (ER)‐negative, progesterone receptor (PR)‐negative, and HER2‐negative invasive breast cancer, the so‐called triple‐negative phenotype , 2007, Cancer.
[36] Graham A. Colditz,et al. Defining breast cancer prognosis based on molecular phenotypes: results from a large cohort study , 2011, Breast Cancer Research and Treatment.
[37] A. Diamant,et al. Income disparities in obesity trends among California adolescents. , 2010, American journal of public health.
[38] T. Naab,et al. Treatment and Survival Outcome for Molecular Breast Cancer Subtypes in Black Women , 2008, Annals of surgery.
[39] E. Ostrander,et al. Frequency of BRCA1/BRCA2 mutations in a population‐based sample of young breast carcinoma cases , 2000, Cancer.
[40] Scarlett L. Gomez,et al. Misclassification of race/ethnicity in a Population-based Cancer Registry (United States) , 2006, Cancer Causes & Control.
[41] R. Prentice,et al. Reproductive history and oral contraceptive use in relation to risk of triple-negative breast cancer. , 2011, Journal of the National Cancer Institute.
[42] Jiaquan Xu,et al. Annual Summary of Vital Statistics: 2007 , 2010, Pediatrics.
[43] C. Shapiro,et al. Trends in breast cancer presentation and care according to age in a single institution. , 2004, American journal of surgery.
[44] Jarvis T. Chen,et al. Temporal trends in the black/white breast cancer case ratio for estrogen receptor status: disparities are historically contingent, not innate , 2011, Cancer Causes & Control.
[45] Jinha M. Park,et al. Diagnostic Evaluation of HER-2 as a Molecular Target: An Assessment of Accuracy and Reproducibility of Laboratory Testing in Large, Prospective, Randomized Clinical Trials , 2005, Clinical Cancer Research.
[46] R. Prentice,et al. Body Size, Physical Activity, and Risk of Triple-Negative and Estrogen Receptor–Positive Breast Cancer , 2011, Cancer Epidemiology, Biomarkers & Prevention.
[47] Charles F. Lynch,et al. Quality of race, Hispanic ethnicity, and immigrant status in population-based cancer registry data: implications for health disparity studies , 2007, Cancer Causes & Control.
[48] S. Sommer,et al. Beyond Li Fraumeni Syndrome: clinical characteristics of families with p53 germline mutations. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[49] L. Newman,et al. Higher population‐based incidence rates of triple‐negative breast cancer among young African‐American women , 2011, Cancer.
[50] A. Kurian,et al. Lifetime risks of specific breast cancer subtypes among women in four racial/ethnic groups , 2010, Breast Cancer Research.